# Polypill and RiscOMeter to Prevent StrOke and CogniTive ImpairmEnt (PROMOTE)

Study · id `cardio:ct-nct05155137` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05155137](<https://clinicaltrials.gov/study/NCT05155137>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05155137

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 8518 participants.

## Technical summary

Registry record NCT05155137. Randomized; quadruple masking; primary purpose prevention. Start 2021-12-20 (actual); primary completion 2029-12-14 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 8518 participants (planned count; ClinicalTrials.gov record NCT05155137, source copy `cardio:ctgov-nct05155137-2025-01-23`, retrieved 2026-10-26)
- Started: 2021-12-20 (actual) (ClinicalTrials.gov record NCT05155137, source copy `cardio:ctgov-nct05155137-2025-01-23`, retrieved 2026-10-26)
- Primary completion: 2029-12-14 (anticipated) (ClinicalTrials.gov record NCT05155137, source copy `cardio:ctgov-nct05155137-2025-01-23`, retrieved 2026-10-26)
- Completion: 2030-12-14 (anticipated) (ClinicalTrials.gov record NCT05155137, source copy `cardio:ctgov-nct05155137-2025-01-23`, retrieved 2026-10-26)
- Countries: Brazil (ClinicalTrials.gov record NCT05155137, source copy `cardio:ctgov-nct05155137-2025-01-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05155137-2025-01-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Polypill and RiscOMeter to Prevent StrOke and CogniTive ImpairmEnt (PROMOTE)
- Acronym: PROMOTE
- Condition: Stroke
- Condition: Cognitive Decline
- Intervention (Drug): Drug Capsule (Valsartan + Amlodipine + Rosuvastatin)
- Intervention (Behavioral): Stroke Riskometer
- Lead sponsor: Hospital Moinhos de Vento
- Lead sponsor class: OTHER
- Collaborator: Ministry of Health, Brazil
- Collaborator class: OTHER\_GOV
- Collaborator: World Stroke Organization
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Hospital Moinhos de Vento (`cardio:org-hospital-moinhos-de-vento`)
- Registry lists this organization as a collaborator: Ministry of Health, Brazil (`cardio:org-ministry-of-health-brazil`)

## Provenance

Content hash: cd12cf9129ad8351c96bc96973331c7d106c6f65630b7e255def1410b7cbe908
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
